10.1007/s10658-007-9236-3 67 HassanW.HussainM.BashirS.ShahA
Consider Bone-Supporting Supplements Collagen peptides may support bone matrix strength
Semaglutide A GLP1 receptor agonist
Nervous system disorders Uncommon: Headache Not known: Convulsions*, Dizziness Heart disease Not known: Palpitations Vascular pathologies Uncommon: Hypertension, Hypotension Respiratory, thoracic and mediastinal pathologies Not known: Dyspnea Gastrointestinal disorders Common: Vomiting, Nausea, Diarrhea, Abdominal pain Uncommon: Dysgeusia, Dyspepsia, Dry mouth Skin and subcutaneous tissue disorders Uncommon: Abnormal skin odor ** Not known: Itching, Skin rash Musculoskeletal and connective tissue disorders Uncommon: Muscle spasms Not known: Myasthenia***, Muscle tension Systemic disorders and conditions related to the administration site Uncommon: Chest pain, Feeling abnormal, Pyrexia, Injection site reaction**** Diagnostic tests Uncommon: Increased blood pressure Very rare: Increased INR*****
Protein (25 g) was loaded on 10% or 12% SDS-PAGE gels, depending on the size of the protein of interest, in 30 l of radioimmunoprecipitation Assay (RIPA) buffer, and run at 120 V
For example, selective FGFR4 agonism, either peripherally or in liver, does not affect fasting glucose in obese diabetic mice, but increases triglycerides and total cholesterol (307, 308)